Increasing Diabetes Prevalence To Boost HbA1c Testing Demand: Transformative Forces Shaping the Hemoglobin A1c (HbA1c) Testing Market Landscape in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Hemoglobin A1c (HbA1c) Testing Industry Market Size Be by 2025?
In recent times, there has been a swift expansion of the market size for Hemoglobin a1c (HbA1c) testing. The market, which was valued at $1.83 billion in 2024, is projected to rise to $2.03 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.7%. This remarkable growth during the historic period is due to factors such as the rising occurrences of diabetes, enhanced awareness and screening initiatives, expanded government efforts and health policies, the surge in healthcare infrastructure, the aging population growth, improved accuracy of diagnostic tools, and a heightened interest in point-of-care testing.

What's the Long-Term Growth Forecast for the Hemoglobin A1c (HbA1c) Testing Market Size Through 2029?
In the coming years, the market for hemoglobin a1c (HbA1c) testing is anticipated to flourish swiftly, escalating to a valuation of $3.02 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The projection for growth in this period is based on factors such as the increasing incidence of lifestyle-related diseases, a more pronounced emphasis on preventive health care, market expansion in emerging regions, the rise of personalized medicine and patient-focused care, regulatory backing and reimbursement policies, as well as the growth of telemedicine and remote monitoring. The forecast period is anticipated to witness major trends, including technological breakthroughs, integration into digital health platforms, advancements in non-invasive testing techniques, telehealth expansion, and the growth of remote patient monitoring.

View the full report here:
https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-hba1c-testing-global-market-report

What Are the Key Growth Drivers Fueling the Hemoglobin A1c (HbA1c) Testing Market Expansion?
The surge in diabetes instances is predicted to boost the hemoglobin A1c (HbA1c) testing market's expansion in the future. Diabetes, a persistent medical condition, hampers the body's ability to control blood glucose levels adequately due to inadequate insulin production or insulin resistance. Factors contributing to the rise in diabetes include an unhealthy diet rich in processed foods and sugary drinks, as well as a lack of physical activity. Additionally, an aging population and a family history of diabetes heighten the likelihood of developing this disease. HbA1c testing aids in the long-term oversight of blood sugar control in diabetics by gauging the mean blood sugar level over the preceding 2-3 months. For example, in June 2023, The Lancet, a UK-based book and periodic data publication organization, forecasted that global diabetes cases would rise from 529 million in 2021 to 1.3 billion by 2050. Thus, the growing incidence of diabetes is anticipated to fuel the hemoglobin A1c (HbA1c) testing market's growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18632&type=smp

What Are the Key Trends Driving Hemoglobin A1c (HbA1c) Testing Market Growth?
Leading businesses in the hemoglobin A1c (HbA1c) testing market are making strides in technological innovation, specifically in diagnostic testing such as HbA1c home tests. These advancements aim to make early diabetes detection and management more accessible, accurate, and convenient. HbA1c home tests are diagnostic home kits designed to give individuals the ability to check their average blood sugar levels over a period of 2-3 months, thus aiding in the monitoring and control of diabetes. For example, in February 2023, Hurdle Health, a US-based company concentrating on the provision of innovative healthcare solutions, including diagnostic equipment for chronic disease control, introduced the Hemoglobin A1c (HbA1c) Test. This recently introduced at-home blood test facilitates adult screening and monitoring of diabetes, further promoting the mission of Chronomics to increase accessibility to diagnostic testing and enhance health outcomes via direct-to-consumer services.

How Is the Hemoglobin A1c (HbA1c) Testing Market Segmented?
The hemoglobin a1c (HbA1c) testing market covered in this report is segmented -

1) By Type: Laboratory Based Testing, Point Of Care (PoC) Testing
2) By Product Type: Instruments, Reagents, Kits
3) By Technology: Immunoassays, Chromatography, Enzymatic Assays, Boronate Affinity Chromatography, High Performance Liquid Chromatography, Other Technologies
4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Homecare Settings, Other End Users

Subsegments:
1) By Laboratory-Based Testing: High-Performance Liquid Chromatography (HPLC) Testing, Ion-Exchange Chromatography, Capillary Electrophoresis, Enzyme-Linked Immunosorbent Assay (ELISA), Mass Spectrometry
2) By Point Of Care (PoC) Testing: Fingerstick Testing Devices, Portable Hba1c Analyzers, Handheld Hba1c Test Kits, Home Use Hba1c Monitoring Devices, Wireless Hba1c Testing Solutions

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18632&type=smp

Which Companies Are Leading the Charge in Hemoglobin A1c (HbA1c) Testing Market Innovation?
Major companies operating in the hemoglobin A1c (HbA1c) testing market are Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Tosoh Corporation, Hitachi High-Technologies Corporation, Beckman Coulter Inc, Sysmex Corporation, Bio Rad Laboratories Inc, ARKRAY Inc, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Agappe Diagnostics Ltd, SEKISUI Diagnostics LLC, Helena Laboratories, Transasia Bio Medicals Ltd, EKF Diagnostics, Trinity Biotech plc, HemoCue AB, CPC Diagnostics Pvt Ltd, PTS Diagnostics, Menarini Diagnostics srl, Diazyme Laboratories Inc, Osang HealthCare Co Ltd, Eurolyser Diagnostica GmbH, DiaSys Diagnostic Systems GmbH

Which Regions Are Leading the Global Hemoglobin A1c (HbA1c) Testing Market in Revenue?
North America was the largest region in the hemoglobin A1c (HbA1c) testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemoglobin A1c (HbA1c) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18632

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.